Pfizer is recalling approximately 185,409 bottles of Zoloft (sertraline HCl) and Diphenoxylate Hydrochloride/Atropine Sulfate tablets due to weight variations that may cause the medication to be too strong or too weak. This recall affects 100-count and 1,000-count bottles of Diphenoxylate/Atropine and 30-count bottles of Zoloft 25 mg tablets distributed nationwide. Because the dosage in these tablets may not be accurate, consumers should immediately contact their healthcare provider or pharmacist for guidance on how to manage their medication regimen.
Variations in tablet weight can lead to 'sub-potent' or 'super-potent' doses, meaning patients may receive significantly less or more medication than prescribed. Receiving an incorrect dose of these medications can lead to a loss of symptom control or an increased risk of serious side effects and toxicity.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.